mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-05 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-05 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-05 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-05 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |